Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Eir
  6. /
  7. QPS, LLC
EIR
•QPS, LLC•December 8, 2017

QPS, LLC – FDA EIR, Dec 8, 2017

Record Details

The FDA conducted a high-priority pre-approval data validation and surveillance inspection of QPS, LLC, a bioanalytical facility in Newark, DE, from December 4 to December 8, 2017. The inspection, under Compliance Program 7348.001 (In Vivo Bioequivalence), audited data for biologics (PHSA 351(k), 21 CFR Part 601) and drugs (FDCA, 21 CFR Part 320), with guidance from Bioanalytical Method Validation recommendations. Notably, no Form FDA 483 (Inspectional Observations) was issued during this inspection, indicating an absence of formal regulatory violations. A previous inspection in December 2016 had cited issues with analyte stability, which were reported as resolved. During the current audit, inspectors identified several discussion points for management consideration. These included inconsistent documentation of sample handling conditions at clinical sites prior to QPS receipt. Concerns were also raised regarding measurable pre-dose concentrations of certain analytes in patient samples, which QPS had re-assayed but not fully investigated for underlying mechanisms. Additionally, the report highlighted unaddressed potential interferences in assay robustness and the impact of the referral process for neutralizing antibody testing on data interpretation. While no immediate corrective actions were mandated, QPS management was invited to provide post-inspectional correspondence on these observations, encouraging future operational enhancements.

Company
QPS, LLC
Inspection date
December 8, 2017
Product type
Biologics
Office
Center for Drug Evaluation and Research
People
  • ChauHwei Fu (company_representative)
  • Wendy Finan (company_representative)
  • Michael F. Skelly (issuing_officer)
  • Xun Wang (company_representative)
  • Hui Zhang (company_representative)
View Company Profile

ID · 2f3e7437-cc79-416d-b36c-00cdab575f30

Violation Codes3
21 CFR 60121 CFR 32021 CFR 312

Full citation text and observation details available on the Dashboard.

Other documents for QPS, LLC
  • 483 - 2026-01-30January 30, 2026
  • EIR - 2019-01-16January 16, 2019
  • EIR - 2017-08-25August 25, 2017
  • EIR - 2013-06-21June 21, 2013

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore QPS, LLC
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.